These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6398155)
1. Lymphocyte subpopulations in Kawasaki disease. Shannon K; Fink CW; Buchanan GR; Punaro M; Stastny P Clin Exp Rheumatol; 1983; 1(1):59-62. PubMed ID: 6398155 [TBL] [Abstract][Full Text] [Related]
2. Decreased CD5+ B cells during the acute phase of Kawasaki disease. Kim HS; Noh GW; Kim DS; Lee KY; Lee HS; Lee HK; Lee SI Yonsei Med J; 1996 Feb; 37(1):52-8. PubMed ID: 8967110 [TBL] [Abstract][Full Text] [Related]
3. Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Terai M; Kohno Y; Niwa K; Toba T; Sakurai N; Nakajima H Am J Cardiol; 1987 Sep; 60(7):555-9. PubMed ID: 3307369 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease. Furukawa S; Matsubara T; Motohashi T; Sasai K; Nakachi S; Umezawa Y; Yabuta K Int Arch Allergy Appl Immunol; 1991; 95(1):7-12. PubMed ID: 1833342 [TBL] [Abstract][Full Text] [Related]
5. Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease. Shingadia D; O'Gorman M; Rowley AH; Shulman ST Pediatr Res; 2001 Oct; 50(4):538-43. PubMed ID: 11568300 [TBL] [Abstract][Full Text] [Related]
6. Allograft Inflammatory Factor-1 Links T-Cell Activation, Interferon Response, and Macrophage Activation in Chronic Kawasaki Disease Arteritis. Rowley AH; Baker SC; Kim KA; Shulman ST; Yang A; Arrollo D; DeBerge M; Han S; Sibinga NES; Pink AJ; Thorp EB J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e94-e102. PubMed ID: 28505365 [TBL] [Abstract][Full Text] [Related]
7. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease. Giordani L; Quaranta MG; Marchesi A; Straface E; Pietraforte D; Villani A; Malorni W; Del Principe D; Viora M Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593 [TBL] [Abstract][Full Text] [Related]
8. [T-lymphocyte subpopulations in chronic inflammatory rheumatism]. Faure G; Bach MA; Bene MC; Kahn MF; Bach JF; Gaucher A Rev Rhum Mal Osteoartic; 1982 May; 49(6):439-45. PubMed ID: 6213999 [TBL] [Abstract][Full Text] [Related]
9. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease. Reichardt P; Lehmann I; Sierig G; Borte M Infection; 2002 Dec; 30(6):360-4. PubMed ID: 12478326 [TBL] [Abstract][Full Text] [Related]
10. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease]. Zhang YY; Huang XM; Kang ML; Gong FQ; Qian BQ Zhonghua Er Ke Za Zhi; 2006 May; 44(5):329-32. PubMed ID: 16780706 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood lymphocyte subpopulations after splenectomy for trauma. Chelazzi G; Senaldi G; Pinotti G; Nicora C; Rossi D; Mondelli M Boll Ist Sieroter Milan; 1987; 66(2):120-3. PubMed ID: 3311078 [TBL] [Abstract][Full Text] [Related]
13. Lymphocyte subpopulations during acute and convalescence phases of malaria. Tongtawe P; Chaicumpa W; Tapchaisri P; Looareesuwan S; Webster HK Asian Pac J Allergy Immunol; 1988 Jun; 6(1):11-8. PubMed ID: 3048287 [TBL] [Abstract][Full Text] [Related]
14. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies. Mascart-Lemone F; Delespesse G; Dorchy H; Lemiere B; Servais G Clin Exp Immunol; 1982 Feb; 47(2):296-300. PubMed ID: 6210472 [TBL] [Abstract][Full Text] [Related]
15. [Study on peripheral blood mononuclear cell subpopulations in children. Part II. Peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease]. Ogiwara A Arerugi; 1984 Jul; 33(7):369-75. PubMed ID: 6497666 [No Abstract] [Full Text] [Related]
16. Increased percentages of tumor necrosis factor-alpha+/interferon-gamma+ T [corrected] lymphocytes and calprotectin+/tumor necrosis factor-alpha+ monocytes in patients with acute Kawasaki disease. Guggino G; Cimaz R; Accomando S; Pagnini I; Simonini G; Di Liberto D; De Martino M; Dieli F; Sireci G Int J Immunopathol Pharmacol; 2012; 25(1):99-105. PubMed ID: 22507322 [TBL] [Abstract][Full Text] [Related]
17. T lymphocyte subpopulations in myelodysplastic syndromes. Carpani G; Rosti A; Vozzo N Acta Haematol; 1989; 81(4):173-5. PubMed ID: 2502889 [TBL] [Abstract][Full Text] [Related]
18. [Enumeration of T cell subsets in patients with MCLS using monoclonal antibodies]. Seto S; Miyake T; Hirao T Arerugi; 1983 Sep; 32(9):970-8. PubMed ID: 6607721 [No Abstract] [Full Text] [Related]
19. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease. Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the immune system in Down's syndrome patients]. Rascón Trincado MV; Lorente Toledano F; Muriel Ramos MM; Romo Cortina A; Salazar Villalobos V Allergol Immunopathol (Madr); 1984; 12(1):45-52. PubMed ID: 6233858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]